Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society for Antimicrobial Chemotherapy.
暂无分享,去创建一个
J. Sandoe | F. K. Gould | J. Perry | T. Elliott | J. Foweraker | T S J Elliott | J Foweraker | F K Gould | J D Perry | J A T Sandoe | J. Sandoe | F. Gould
[1] I. Shalit,et al. Q fever endocarditis in Israel and a worldwide review. , 1997, Scandinavian journal of infectious diseases.
[2] J. C. West,et al. Review of pneumococcal endocarditis in adults in the penicillin era. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[3] A. Vergara,et al. Prospective evaluation of a two-week course of intravenous antibiotics in intravenous drug addicts with infective endocarditis , 1994, European Journal of Clinical Microbiology and Infectious Diseases.
[4] D. Raoult,et al. Treatment of Q fever endocarditis: comparison of 2 regimens containing doxycycline and ofloxacin or hydroxychloroquine. , 1999, Archives of internal medicine.
[5] R. Jones,et al. Determination of the antimicrobial activity of 29 clinically important compounds tested against fastidious HACEK group organisms. , 1999, Diagnostic microbiology and infectious disease.
[6] M. Sande,et al. Treatment of streptomycin-susceptible and streptomycin-resistant enterococcal endocarditis. , 1984, Annals of internal medicine.
[7] C. Poynton,et al. Polymerase chain reaction aids in the diagnosis of an unusual case of Aspergillus niger endocarditis in a patient with acute myeloid leukaemia. , 2003, The Journal of infection.
[8] Claude Carbón,et al. Value of antibiotic levels in serum and cardiac vegetations for predicting antibacterial effect of ceftriaxone in experimental Escherichia coli endocarditis , 1987, Antimicrobial Agents and Chemotherapy.
[9] K. Fuursted,et al. Different Polymerase Chain Reaction-based Analyses for Culture-negative Endocarditis Caused by Streptococcus pneumoniae , 2003, Scandinavian journal of infectious diseases.
[10] A. Guyot,et al. Culture-Positive Bartonella quintana Endocarditis , 1999, European Journal of Clinical Microbiology and Infectious Diseases.
[11] A. P. Ball,et al. Antibiotic treatment of streptococcal, enterococcal, and staphylococcal endocarditis , 1998, Heart.
[12] P. Francioli,et al. Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone sodium for 4 weeks. Efficacy and outpatient treatment feasibility. , 1992, JAMA.
[13] L. Olaison,et al. Enterococcal endocarditis in Sweden, 1995-1999: can shorter therapy with aminoglycosides be used? , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] V. Fowler,et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] S. Finegold,et al. Endocarditis due to anaerobic gram-negative bacilli. , 1973, The American journal of medicine.
[16] N. Snyder,et al. Increased concurrence of cirrhosis and bacterial endocarditis. A clinical and postmortem study. , 1977, Gastroenterology.
[17] W. Wilson,et al. Ciprofloxacin therapy of experimental endocarditis caused by methicillin-resistant Staphylococcus epidermidis , 1990, Antimicrobial Agents and Chemotherapy.
[18] V. Andriole,et al. Streptococcal endocarditis (nonenterococcal, non-group A): single vs combination therapy. , 1979, JAMA.
[19] J. Sobel,et al. Guidelines for treatment of candidiasis. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[20] R. Macgregor,et al. Cardiobacterium hominis: an elusive cause of endocarditis. , 1983, The Journal of infection.
[21] P. Martín-Dávila,et al. Short-course therapy for right-side endocarditis due to Staphylococcus aureus in drug abusers: cloxacillin versus glycopeptides in combination with gentamicin. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[22] Sunil V. Rao,et al. Mayo Clinic Proceedings , 2000 .
[23] R. H. Parker,et al. Intravenous followed by oral antimicrobial therapy for staphylococcal endocarditis. , 1980, Annals of internal medicine.
[24] S. Eykyn,et al. Suggested modifications to the Duke criteria for the clinical diagnosis of native valve and prosthetic valve endocarditis: analysis of 118 pathologically proven cases. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[25] C. Fìlice,et al. Management of staphylococcal endocarditis in drug addicts. Combined therapy with oral rifampicin and aminoglycosides. , 1984, The Journal of antimicrobial chemotherapy.
[26] Didier Raoult,et al. Culture of Bartonella quintana andBartonella henselae from Human Samples: a 5-Year Experience (1993 to 1998) , 1999, Journal of Clinical Microbiology.
[27] S. Moreno,et al. Endocarditis due to ampicillin-resistant nontyphoid Salmonella: cure with a third-generation cephalosporin. , 1990, Reviews of infectious diseases.
[28] N. Frimodt-Møller,et al. Antibiotic treatment of Staphylococcus aureus endocarditis. A review of 119 cases. , 2009, Acta medica Scandinavica.
[29] R. Steelman,et al. Increased susceptibility to gingival colonization by specific HACEK microbes in children with congenital heart disease. , 2001, The Journal of clinical pediatric dentistry.
[30] P. Gallagher,et al. Group B streptococcal endocarditis: report of seven cases and review of the literature, 1962-1985. , 1986, Reviews of infectious diseases.
[31] R. Auckenthaler,et al. Early termination of a prospective, randomized trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infections. , 1987, The Journal of infectious diseases.
[32] R. Zbinden,et al. Etiologic diagnosis of infective endocarditis by broad-range polymerase chain reaction: a 3-year experience. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[33] D. Raoult,et al. Diagnosis of 22 New Cases of Bartonella Endocarditis , 1996, Annals of Internal Medicine.
[34] D. Raoult,et al. Diagnostic methods current best practices and guidelines for identification of difficult-to-culture pathogens in infective endocarditis. , 2002, Infectious disease clinics of North America.
[35] P. Serra,et al. 4-week treatment of streptococcal native valve endocarditis with high-dose teicoplanin , 1992, Antimicrobial Agents and Chemotherapy.
[36] A. Karchmer,et al. Infections of intracardiac devices. , 2002, Infectious disease clinics of North America.
[37] G. Rolinson,et al. Flucloxacillin, a New Isoxazolyl Penicillin, Compared with Oxacillin, Cloxacillin, and Dicloxacillin , 1970, British medical journal.
[38] C. Watanakunakorn,et al. Group A streptococcus endocarditis: report of five cases and review of literature. , 1991, The Journal of infection.
[39] D. Denning,et al. Practice Guidelines for Diseases Caused by Aspergillus , 2000 .
[40] Didier Raoult,et al. Outcome and treatment of Bartonella endocarditis. , 2003, Archives of internal medicine.
[41] Tamer Ma,et al. Trimethoprim-Sulfamethoxazole Treatment of Multiantibiotic-Resistant Staphylococcal Endocarditis and Meningitis , 1982 .
[42] C. A. Wood,et al. Failure of treatment with teicoplanin at 6 milligrams/kilogram/day in patients with Staphylococcus aureus intravascular infection. The Infectious Diseases Consortium of Oregon , 1991, Antimicrobial Agents and Chemotherapy.
[43] P. Davey,et al. Teicoplanin monotherapy of serious infections caused by gram-positive bacteria: a re-evaluation of patients with endocarditis or Staphylococcus aureus bacteraemia from a European open trial. , 1991, Journal of Antimicrobial Chemotherapy.
[44] R. Haug. New criteria for diagnosis of infective endocarditis: Utilization of specific echocardiographic findings , 1994 .
[45] K. Luh,et al. Actinobacillus actinomycetemcomitans endocarditis: a report of four cases and review of the literature. , 1991, The Quarterly journal of medicine.
[46] J. Timpone,et al. Penicillin-resistant Streptococcus pneumoniae endocarditis: a case report and review. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[47] H. Lepidi,et al. Molecular Diagnosis of Infective Endocarditis by PCR Amplification and Direct Sequencing of DNA from Valve Tissue , 2003, Journal of Clinical Microbiology.
[48] J. Felner,et al. Anaerobic bacterial endocarditis. , 1970, The New England journal of medicine.
[49] J. Duval,et al. Fusidic acid alone or in combination with vancomycin for therapy of experimental endocarditis due to methicillin-resistant Staphylococcus aureus , 1993, Antimicrobial Agents and Chemotherapy.
[50] M. Wallace,et al. Stenotrophomonas maltophilia Endocarditis , 2002, Scandinavian journal of infectious diseases.
[51] D Raoult,et al. Modification of the diagnostic criteria proposed by the Duke Endocarditis Service to permit improved diagnosis of Q fever endocarditis. , 1996, The American journal of medicine.
[52] A. Bayer,et al. Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations. , 1985, The Journal of infectious diseases.
[53] J. Washington,et al. The microbiological diagnosis of infective endocarditis. , 1987, The Journal of antimicrobial chemotherapy.
[54] S. Palmer,et al. Q-FEVER ENDOCARDITIS IN ENGLAND AND WALES, 1975-81 , 1982, The Lancet.
[55] R. Greenman,et al. Single or combination therapy of staphylococcal endocarditis in intravenous drug abusers. , 1979, Annals of internal medicine.
[56] D. Raoult,et al. Comparison of different antibiotic regimens for therapy of 32 cases of Q fever endocarditis , 1991, Antimicrobial Agents and Chemotherapy.
[57] A. Bolger,et al. Diagnosis and management of infective endocarditis and its complications. , 1998, Circulation.
[58] M. González,et al. Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[59] S. Eykyn,et al. Culture-negative endocarditis: contribution of bartonella infections. , 1997, Heart.
[60] M. Whitby. Fusidic acid in septicaemia and endocarditis. , 1999, International journal of antimicrobial agents.
[61] A. Badley,et al. Infective endocarditis caused by HACEK microorganisms. , 1997, Annual review of medicine.
[62] G. Doern. Detection of selected fastidious bacteria. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[63] J. Perfect,et al. Treatment of methicillin-resistant Staphylococcus aureus infections with quinupristin–dalfopristin in patients intolerant of or failing prior therapy , 2000 .
[64] Jerome J. Schentag,et al. Integration of pharmacokinetics and pharmacodynamics of methicillin in curative treatment of experimental endocarditis. , 1984, The Journal of antimicrobial chemotherapy.
[65] R. T. Miller,et al. Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy. , 1988, Annals of internal medicine.
[66] W. Dismukes,et al. Citrobacter diversus endocarditis. , 2000, The American journal of the medical sciences.
[67] D. Levine,et al. Bacteremia in narcotic addicts at the Detroit Medical Center. II. Infectious endocarditis: a prospective comparative study. , 1986, Reviews of infectious diseases.
[68] D. Durack,et al. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. , 1994, The American journal of medicine.
[69] D. Raoult,et al. Bartonella (Rochalimaea) quintana endocarditis in three homeless men. , 1995, The New England journal of medicine.
[70] Jerome J. Schentag,et al. Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[71] C Flexner,et al. Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy. , 1996, The American journal of medicine.
[72] W. Littler,et al. The microbial diagnosis of infective endocarditis. , 2003, The Journal of infection.
[73] E. Mylonakis,et al. Infective endocarditis in adults. , 2001, The New England journal of medicine.
[74] A. Osoba,et al. HACEK group endocarditis at the Riyadh Armed Forces Hospital. , 1997, The Journal of infection.
[75] D. Raoult,et al. Current Knowledge of Bartonella Species , 2022 .
[76] L. Lutwick,et al. Infective endocarditis of a native valve due to Acinetobacter: case report and review. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[77] C. Watanakunakorn,et al. Antagonism Between Nafcillin or Oxacillin and Rifampin Against Staphylococcus aureus , 1982, Antimicrobial Agents and Chemotherapy.
[78] M. Sande,et al. Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: A prospective study. , 1982, Annals of internal medicine.
[79] G. Jackson,et al. Long-term oral ciprofloxacin: experience in the treatment of incurable infective endocarditis. , 1988, The American journal of medicine.
[80] L. Fenelon,et al. Nosocomial infective endocarditis. , 2000, The Journal of hospital infection.
[81] D. Raoult,et al. Mycoplasma endocarditis: two case reports and a review. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[82] R. Bologna,et al. Antibiotic management of outpatients with endocarditis due to penicillin-susceptible streptococci. , 1991, Reviews of infectious diseases.
[83] P. Berche,et al. Emergence of vancomycin resistance in the genus Streptococcus: characterization of a vanB transferable determinant in Streptococcus bovis , 1997, Antimicrobial agents and chemotherapy.
[84] D. Raoult,et al. Endocarditis Due to Rare and Fastidious Bacteria , 2001, Clinical Microbiology Reviews.
[85] S. Eykyn,et al. Campylobacter fetus endocarditis: two case reports and review. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[86] D. Raoult,et al. Chronic Q Fever: Ninety-two Cases From France, Including 27 Cases Without Endocarditis , 1993 .
[87] R. Hershow,et al. Retrospective Evaluation of Therapies for Staphylococcus aureus Endocarditis , 1997, Pharmacotherapy.
[88] Claude Carbón,et al. Pharmacokinetic and pharmacodynamic requirements for antibiotic therapy of experimental endocarditis , 1992, Antimicrobial Agents and Chemotherapy.
[89] B. Fantin,et al. In vivo antibiotic synergism: contribution of animal models , 1992, Antimicrobial Agents and Chemotherapy.
[90] Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association. , 1995, JAMA.
[91] T. Yipintsoi,et al. Intravenous followed by oral antimicrobial therapy for staphylococcal endocarditis. , 1993, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.
[92] A. Adgey,et al. Clinical Q fever in Northern Ireland 1962-1989. , 1990, The Ulster medical journal.
[93] W. Wilson,et al. Treatment of streptococcal infective endocarditis. , 1985, The American journal of medicine.
[94] T. Rakowski,et al. Therapy with RP 59500 (quinupristin/dalfopristin) for prosthetic valve endocarditis due to enterococci with VanA/VanB resistance patterns. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[95] F. Cockerill,et al. Infective endocarditis due to unusual or fastidious microorganisms. , 1997, Mayo Clinic proceedings.
[96] B. R. Reddy,et al. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. , 1991, Annals of internal medicine.
[97] D. Raoult,et al. Q Fever 1985‐1998: Clinical and Epidemiologic Features of 1,383 Infections , 2000, Medicine.
[98] H. B. T. Brooks,et al. Diagnostic Methods , 1916, The Indian Medical Gazette.
[99] J. Andrews,et al. Determination of minimum inhibitory concentrations. , 2001, The Journal of antimicrobial chemotherapy.
[100] P S Cohen,et al. Infective endocarditis caused by gram-negative bacteria: a review of the literature, 1945-1977. , 1980, Progress in cardiovascular diseases.
[101] J. Benedik,et al. Molecular diagnosis of culture negative infective endocarditis: clinical validation in a group of surgically treated patients , 2003, Heart.
[102] I. Smith,et al. Infective endocarditis with negative blood cultures. An analysis of 52 cases. , 1979, The American journal of medicine.
[103] D. Mesa,et al. Long term outcome of infective endocarditis in patients who were not drug addicts: a 10 year study , 2000, Heart.
[104] H. Gaya,et al. Treatment of endocarditis with teicoplanin: a retrospective analysis of 104 cases. , 1996, The Journal of antimicrobial chemotherapy.
[105] D. Levine,et al. Bacteremia in narcotic addicts at the Detroit Medical Center. I. Microbiology, epidemiology, risk factors, and empiric therapy. , 1986, Reviews of infectious diseases.